SaudiVax to increase halal vaccine availability in the Middle East with FlexFactory from Cytiva
- SaudiVax intends to increase access to vaccines to 20 times more people in the Middle East and Africa than today
- First bioprocessing facility for halal vaccines in-region, for region
- Remote Factory Acceptance Testing (FAT) helped avoid COVID-19 related delays
November 17, 2020 - Cytiva, a global life sciences leader, is installing its first FlexFactory in the Middle East and North African region as part of SaudiVax’s planned Saudi Vaccine and Bioprocessing Center (SVBC), a Saudi government-funded project led by King Abdulaziz City for Science and Technology and the National Industrial Development Center. The SVBC will use Cytiva’s FlexFactory to manufacture halal vaccines and biologics in-region, for-region, as part of an effort to heighten protection against the spread of communicable diseases among Saudi residents and visitors to the region.
Free, in under 30 seconds
Join thousands of professionals reading Salaam Gateway — the Global Islamic Economy Gateway.
Already a member? Sign in
- 5 free articles every month
- Weekly Islamic-economy newsletter
- Save articles to read later
Press Release